Results 251 to 260 of about 585,558 (296)
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source
This review provides an overview of triboelectric nanogenerator (TENG)–based biomedical applications by classifying studies into electronic and ionic systems across attachable and implantable platforms. It summarizes key material choices, device structures, and working mechanisms that characterize current TENG‐based research, and outlines six future ...
Kyongtae Choi +12 more
wiley +1 more source
Non‐Invasive Brain Targeted Delivery of Cannabidiol for Alleviating Neuroinflammatory Disease
The glucose‐functionalized nanoparticles (GNPs) are developed for the brain‐targeted delivery of cannabidiol (CBD). GNPs bypass the blood‐brain barrier (BBB) via glucose transporter‐1 (GLUT‐1) and release CBD in response to reactive oxygen species (ROS).
Yibin Wang +7 more
wiley +1 more source
A nano‐interception strategy disrupts pathogenic fibroblast–macrophage crosstalk in chronic heart failure. Scalable Prussian blue nanoparticles selectively sequester CCL2 via ultrahigh‐affinity binding, preventing CCR2+ macrophage recruitment and breaking a key fibro‐inflammatory circuit. This approach demonstrates robust efficacy in murine and porcine
Bo Chen +16 more
wiley +1 more source
A bioinspired nanozyme—triphenylphosphonium (TPP)‐dendritic mesoporous silica nanoparticle (DMSN)‐Fe/Cu—mimics mitochondrial complex IV and targets mitochondria to regulate cellular energy metabolism. This approach markedly boosts bone regeneration in vivo, as demonstrated by enhanced bone volume and mineral density in critical‐sized bone defects rat ...
Yuwen Wang +16 more
wiley +1 more source
SPARC (spatio‐chimeric, plasma‐based, anisotropic, and shear‐responsive construct) that integrates myogenic and vascular microenvironments within a single construct. The dual‐modulus matrix directs aligned myotube formation and endothelial network development, enabling a vascularized muscle implant that seamlessly anastomoses with host tissue and ...
Su Hyun Jung +6 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Preserflo MicroShunt: Efficacy and Endothelial Cell Density
Journal of Glaucoma, 2023Précis: A main safety concern associated with new glaucoma implants is corneal endothelial cell loss, which could even be observed in already established procedures. Purpose: The purpose of this study was to evaluate the efficacy and corneal safety, especially corneal endothelial ...
Friedrich, Anton Steindor +5 more
openaire +2 more sources
Corneal endothelial cell density in patients receiving chemotherapy
Cutaneous and Ocular Toxicology, 2021This study aimed to determine if the corneal endothelium was affected by chemotherapy.Chemotherapy patients were recruited to undergo specular microscopy before treatment and again at 1- and 2-year follow-up visits. One eye per patient, per follow-up, was selected for comparison to baseline.Forty-six volunteers completed baseline and at least one ...
Shawn P. Gallagher +2 more
openaire +2 more sources
Corneal Endothelial Cell Density in Glaucoma
Cornea, 1997We studied corneal endothelial cell density in patients with glaucoma.One hundred two patients with glaucoma were compared with 52 patients without glaucoma of the same age group. Exclusion criteria included history of either corneal disease, ocular inflammation, trauma, or surgery other than peripheral iridectomy.
M M, Gagnon +4 more
openaire +2 more sources
Postmortem Interval Estimation With Corneal Endothelial Cell Density
American Journal of Forensic Medicine & Pathology, 2021Objectives In the neonatal period, healthy people have the highest corneal endothelial cell density (CECD) (5000–7000 cells/mm2). Corneal endothelial cell density declines with age in adults (2500–3000 cells/mm2) and continues to decline in the postmortem period. We measured CECD in cases with different postmortem interval (PMI)
AKYOL, MESUT +6 more
openaire +4 more sources

